Zacharon Pharmaceuticals
Zacharon Pharmaceuticals employs its glycobiology expertise to develop a new class of human therapeutics targeting glycans.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD3—5m (Dealroom.co estimates Jun 2010.)
San Diego California (HQ)
Authorizing premium user...